Barclays
LJPC

Barclays’s La Jolla Pharmaceutical Company LJPC Stock Holding History

Barclays’s Portfolio LJPC Stock Details LJPC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-30,000
Closed -$875K – 7732
2018
Q2 		$875K Buy
+30,000
New +$926K ﹤0.01% 3432

Barclays's LJPC Position: Q3 2022 in Review

Barclays sold out of La Jolla Pharmaceutical Company (LJPC) in Q3 2022, closing a stake of 5,352 shares — an estimated $17K sold.

Barclays first reported a position in LJPC in Q2 2014 and held it in 30 quarters. The position peaked at $2.85M in Q3 2018. 0 funds tracked by Wall St. Rank hold LJPC as of Q3 2022.

  • Barclays reported no remaining La Jolla Pharmaceutical Company position as of Q3 2022 after selling out during the quarter.
  • Barclays sold 5,352 La Jolla Pharmaceutical Company shares in Q3 2022, an estimated $17K.
  • Barclays first reported a position in La Jolla Pharmaceutical Company in Q2 2014 and held it in 30 quarters.
  • Barclays's La Jolla Pharmaceutical Company position peaked at $2.85M in Q3 2018.
  • 0 funds tracked by Wall St. Rank held La Jolla Pharmaceutical Company as of Q3 2022.

Based on Barclays's 13F filing for Q3 2022, filed 3 Nov 2022.